TRACON Pharmaceuticals - Stock Price History | TCON

Historical daily share price chart and data for TRACON Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for TRACON Pharmaceuticals as of September 27, 2021 is 4.40.
  • The all-time high TRACON Pharmaceuticals stock closing price was 184.40 on March 03, 2015.
  • The TRACON Pharmaceuticals 52-week high stock price is 12.20, which is 177.3% above the current share price.
  • The TRACON Pharmaceuticals 52-week low stock price is 3.21, which is 27% below the current share price.
  • The average TRACON Pharmaceuticals stock price for the last 52 weeks is 6.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
TRACON Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.6425 2.6600 11.7000 1.0900 11.7000 400.00%
2019 6.7351 7.1420 17.0000 2.2500 2.3400 -62.86%
2018 22.6222 35.0000 35.0000 5.8000 6.3000 -81.19%
2017 32.8355 53.0000 56.0000 20.0000 33.5000 -31.63%
2016 62.6373 91.7000 91.7000 41.9000 49.0000 -46.97%
2015 114.9813 94.0000 184.4000 84.0000 92.4000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.085B $0.003B
TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29